It is a pharma private limited company based in Chennai, Tamil Nadu, India, established in 1980.
1980 | Chennai, Tamil Nadu, India | ActiveBulwark Laboratories Private Limited, a active private limited company, was established on 21 January 1980 in Chennai, Tamil Nadu, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U85195TN1980PTC008090. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹0.20 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Rosh Thomas (Director), Padmana Thomas (Director), Maya Rosh Thomas (Director). Past directors included Thomas Thomas, Maya Rosh Thomas. It holds ₹2.60 Cr open charges and ₹5.00 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 2/279, Pillayar Koil Street Thoraipakkam, Chennai, Tamil Nadu, 600097.
U85195TN1980PTC008090
008090
21 January 1980
₹0.20 M
₹0.10 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Bulwark Laboratories Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rosh Thomas | Director | 19 Sep 2005 | Current |
| Padmana Thomas | Director | 21 Jan 1980 | Current |
| Maya Rosh Thomas | Director | 16 Aug 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 28 Jan 2022 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Bulwark Laboratories Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 60.29% decrease. The company also saw a substantial fall in profitability, with a 143.1% decrease in profit. The company's net worth observed a substantial decline by a decrease of 10.46%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Bulwark Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹26,000,000.00
₹5,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Mar 2021 | Others | ₹2.60 Cr | Open |
| 16 Nov 2016 | Others | ₹5.00 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Bulwark Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Bulwark Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bulwark Laboratories's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others of Rs. 26.00 M registered on 19 Mar 2021 with Charge ID 100445435 was modified on 04 Feb 2025. was recorded as a recent event.
Bulwark Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Bulwark Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was completed.
Progress on A charge with Others amounted to Rs. 26.00 M with Charge ID 100445435 was registered on 19 Mar 2021. was documented.
A charge registered on 16 Nov 2016 via Charge ID 100063205 with Others was fully satisfied on 19 Mar 2021. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 5.00 M with Charge ID 100063205 was registered on 16 Nov 2016. was documented.
The CIN of Bulwark Laboratories Private Limited is U85195TN1980PTC008090.
Bulwark Laboratories Private Limited is headquartered at 2/279, Pillayar Koil Street Thoraipakkam, Chennai, Tamil Nadu, 600097.
Bulwark Laboratories Private Limited was incorporated on 21 January 1980.
The current directors of Bulwark Laboratories Private Limited are
The primary industry of Bulwark Laboratories Private Limited is Pharma.
Bulwark Laboratories Private Limited is unlisted.
The authorized capital of Bulwark Laboratories Private Limited is ₹0.20 M, and the paid-up capital is ₹0.10 M.
The compliance status of Bulwark Laboratories Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX